【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2190次   下载 1776 本文二维码信息
码上扫一扫!
胰高血糖素样肽-1缓解糖尿病周围神经病变的机制研究进展
温旭东1,汤玮2,刘志民2*
0
(1.第二军医大学研究生管理大队,上海 200433; 2.第二军医大学长征医院内分泌科,上海 200003)
摘要:
糖尿病周围神经病变是糖尿病最常见的并发症之一。胰高血糖素样肽-1(glucagon-like peptides 1, GLP-1)在控制血糖、保护神经、改善微循环、抗氧化应激及调节脂质代谢等方面发挥重要作用,可能与糖尿病周围神经病变的发生、发展密切相关,是目前相关研究的热点。本文就GLP-1与糖尿病周围神经病变的相关性及其作用机制研究进展作一综述。
关键词:  胰高血糖素样肽1  糖尿病周围神经病变  发病机制
DOI:10.3724/SP.J.1008.2011.0329
投稿时间:2010-08-12修订日期:2011-02-01
基金项目:国家自然科学基金面上项目(30872416),上海市科委自然科学基金(10ZR1439400).
Glucagon-like peptide-1 alleviating peripheral neuropathy in diabetic patients: advance in mechanism
WEN Xu-dong1, TANG Wei2, LIU Zhi-min2*
(1. School of Graduate Students, Second Military Medical University, Shanghai 200433, China; 2. Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China)
Abstract:
Peripheral neuropathy is a common complication of patients with diabetes mellitus.Glucagon-like peptide-1 (GLP-1) is known to play important roles in glucose control, neural protection, improving microcirculation, anti-oxidation and lipid metabolism; it is thought to be closely related to the development and progression of diabetic peripheral neuropathy, and it has become a focus of study in the area. This paper introduces the recent researches concerning the association of GLP-1 with diabetic peripheral neuropathy and the related mechanism.
Key words:  glucagon-like peptide 1  diabetic peripheral neuropathy  pathogenesis